Author's reply to correspondence 'influenza like illness related clinical trial on AYUSH-64 requires cautious interpretation'

J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100487. doi: 10.1016/j.jaim.2021.07.003. Epub 2021 Dec 27.

¹ Research Officer (Ayu), RRAP Central Ayurveda Research Institute for Cancer (CCRAS), Mumbai, India. Electronic address: gundetipanchakarma@gmail.com.
² Research Officer (Ayu), RRAP Central Ayurveda Research Institute for Cancer (CCRAS), Mumbai, India.
³ Consultant (Internal Medicine), RRAP Central Ayurveda Research Institute for Cancer (CCRAS), Mumbai, India.
⁴ Senior Research Fellow (Ayu), RRAP Central Ayurveda Research Institute for Cancer (CCRAS), Mumbai, India.
⁵ Research Officer (Ayu), Central Council for Research in Ayurvedic Sciences, Ministry of AYUSH, GoI, New Delhi, India.
⁶ Statistical Officer, Central Council for Research in Ayurvedic Sciences, Ministry of AYUSH, GoI, New Delhi, India.
⁷ Statistical Assistant, Central Council for Research in Ayurvedic Sciences, Ministry of AYUSH, GoI, New Delhi, India.
⁸ Assistant Director (Medicine), Central Council for Research in Ayurvedic Sciences, Ministry of AYUSH, GoI, New Delhi, India.
⁹ Deputy Director General, Central Council for Research in Ayurvedic Sciences, Ministry of AYUSH, GoI, New Delhi, India.
¹⁰ Director General, Central Council for Research in Ayurvedic Sciences, Ministry of AYUSH, GoI, New Delhi, India.

No abstract available

Publication types